ALGN250417P165000
- 0.03
- -1.01-97.12%
Align Technology Newsroom
Notable Healthcare Headlines for the Week: UnitedHealth, Eli Lilly, J&J in Focus
Short Bets Against S&P 500 Healthcare Stock Rises in March; MRNA Stays Top Shorted
Piper Sandler Maintains Align Technology(ALGN.US) With Buy Rating, Maintains Target Price $235
Morgan Stanley Maintains Align Technology(ALGN.US) With Buy Rating, Cuts Target Price to $249
Dentsply Sirona Downgraded at Morgan Stanley on Macro/ Demand Headwinds
Morgan Stanley Adjusts Align Technology Price Target to $249 From $272, Maintains Overweight Rating
Stifel Maintains Align Technology(ALGN.US) With Buy Rating, Announces Target Price $275
Express News | Align Technology Inc : Leerink Partners Cuts Target Price to $231 From $277
Align Technology (ALGN) Moves 14.4% Higher: Will This Strength Last?
Evercore ISI Adjusts Price Target on Align Technology to $165 From $260, Maintains Outperform Rating
Is Now An Opportune Moment To Examine Align Technology, Inc. (NASDAQ:ALGN)?
Mizuho Securities Maintains Align Technology(ALGN.US) With Buy Rating, Maintains Target Price $250
Align Technology (NASDAQ:ALGN) Will Want To Turn Around Its Return Trends
Align Technology Inc. Stock Rallies 3.7%, Outperforms Competitors
Align Technology Announces Commercial Availability of Invisalign With Mandibula
Express News | Align Technology Announces Invisalign® System With Mandibular Advancement Featuring Occlusal Blocks for Class II Skeletal and Dental Correction
CVS, COR, Among Top S&P 500 Healthcare Gainers in Q1; WST and MRNA Among Losers
Press Release: Align Technology to Announce First Quarter 2025 Results on April 30, 2025
Align Technology Announces Invisalign System With Mandibular Advancement Featuring Occlusal Blocks for Class II Skeletal and Dental Correction
Align Technology to Announce First Quarter 2025 Results on April 30, 2025